Return to homepagePandemic Pact

Biomarkers for risk assessment of patients with COVID-19 - Interregional Biobank project

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $219,552

  • Funder

    Novo Nordisk Foundation

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    Herlev & Gentofte Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The purpose of the project is to create a large, unselected biobank for patients who have been hospitalized with COVID-19. The biobank will be used for 1) identifying and comparing established as well as experimental biomarkers for serious illness and death; and 2) building a risk model that includes one or more markers as well as clinical data. The risk model can be used to assess which patients are at risk of serious illness and which patients will require less intensive monitoring, possibly from their homes. The project is a prospective cohort study.